PATENT CLAIM ANALYSIS

Application Number: 16137167
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "531000"]

Abstract:
The present specification provides methods of treating disease with an ester of an RXR agonist or a combination of an ester of an RXR agonist and a thyroid hormone. The esters of an RXR agonist can be useful in the treatment of cancer, nervous system, autoimmune, and muscular disorders.

Claim (Index 18):
The method of  claim 15 , wherein the IRX4204 ethyl ester is administered at a dosage that produces a systemic concentration of IRX4204 \u22651 nM.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 97.0
- Lexical Diversity: 1.58824
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16118001', '15812821', '15339752', '15339762', '14507730']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.863288857629493
- 35 USC 102 Novelty (BERT): 0.5835468812773569
- Combined Prediction Score: 0.8353146599942795
- Mean Citation Score: 499.71820400000007
- Max Citation Score: 544.04443
- Similarity Product: 341.2846615566969

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test